Developer of next-generation inhalable drugs.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Funding round Nebu~Flow, a Glasgow inhalable-drugs biotech, raised GBP4.7M led by SCVC. | $5.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.